eli lilly glp 1 pipeline Market Overview: GLP-1 Agonists and the Obesity Market | Blog A look at the R&D

BMJ 341:c2701 Manfield JH et al (2017) Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension

TGR5 and FXR are expressed in enteroendocrine L-cells in the intestine

"I feel that this stage of life, and this journey, is totally, totally doable, that we can go through menopause, and we can go through this journey, and actually have a full life and live in wellness," Cockrell told "GMA." Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd

BodySpec looked at a subset of their own patients, many of which were undergoing GLP-1 treatment, who had lost 50+ lbs over the last yea

The regulatory landscape for compounded GLP-1 programs has shifted meaningfully since early 2025, and anyone committing to a multi-month program deserves a plain-English summary of exactly where things stand